The Gross Margin of BioNexus Gene Lab Corp (BGLC) is 13.61%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 13.61% |
2022-12-31 | 11.53% |
2021-12-31 | 16.99% |
2020-12-31 | 15.10% |
2019-12-31 | 46.15% |
2018-12-31 | 14.29% |
2017-12-31 | 72.73% |